Revista Mexicana de Oftalmología

Register      Login

VOLUME 94 , ISSUE 6E ( November-December, 2020 ) > List of Articles

Original Article

COVID-19 and anxiety in ophtalmologists

José R. Mier-Bolio, José M. Arroyo-González, Elizabeth Baques-Guillén, José F. Valdez-Lopez, Álvaro J. Torre-García, Olivia E. Rodríguez-Rodríguez, Gerardo Rivera-Arroyo

Keywords : Anxiety, Ophthalmologists, COVID-19, SARS-CoV-2, Pandemic

Citation Information : Mier-Bolio JR, Arroyo-González JM, Baques-Guillén E, Valdez-Lopez JF, Torre-García ÁJ, Rodríguez-Rodríguez OE, Rivera-Arroyo G. COVID-19 and anxiety in ophtalmologists. 2020; 94 (6E):223-227.

DOI: 10.24875/RMOE.M20000132

License: CC BY-NC-ND 4.0

Published Online: 09-11-2020

Copyright Statement:  Copyright © 2020 Sociedad Mexicana de Oftalmología. Published by Permanyer


Objective: To determine the prevalence of anxiety in ophthalmologists during the COVID-19 (coronavirus disease 2019) pandemic, exposed to severe acute respiratory syndrome by coronavirus type 2 (SARS-CoV-2) working in respiratory triage and outpatient ophthalmology consultation at the Hospital Central Militar in Mexico City. Material and methods: Observational, cross-sectional, descriptive and prospective study, in which a descriptive survey was applied via internet evaluating two anxiety scales (Hamilton scale and generalized anxiety disorder [GAD-7) scale). Results: Thirty-one subjects responded, 17 (54.84%) female and 14 (45.16%) male. Minimum age was 25 years and maximum age was 49 years, with an average age of 34.5 years. The survey consisted of 24 questions, of which 21 were obtained from both anxiety scales (Hamilton + GAD-7) and the remaining three were of epidemiological interest. By rating both scales separately, we observed an average score of 5.16 for the GAD-7 scale and of 8.45 for the Hamilton scale, reflecting a minimal group anxiety. Using the GAD-7 scale, we observed an anxiety prevalence of 48% (15 physicians). Of the diagnosed cases, 9 (60%) met a score listed as mild anxiety, 5 (53%) as moderate and 1 (7%) as severe. On the Hamilton scale, the prevalence was of 83% (26 physicians). Of the diagnosed cases, 23 (88%) had minimal anxiety, 2 (8%) had minimal-moderate anxiety and 1 (4%) had severe anxiety. Conclusion: The prevalence of anxiety in ophthalmologists, using the GAD-7 and Hamilton scales was of 48% and 83%, respectively, and most cases were of mild intensity

PDF Share
  1. CENETEC Trastornos de ansiedad. Guía de Referencia Rápida. Diagnóstico y tratamiento de los trastornos de ansiedad en el adulto. 2010. Disponible en:
  2. Parrish RK II, Stewart MW, Duncan Powers SL. Ophthalmologists Are More Than Eye Doctors—In Memoriam Li Wenliang. Am J Ophthalmol. 2020;213:A1-A2.
  3. Wenliang L, Year LN. All eyes on Coronavirus — What do we need to know as ophthalmologists. Indian J Ophthalmol. 2020;68(4):549-53.
  4. Emparan JPO, Garza-Leon M, García-Aguirre G, Azcárate-Coral T, Penniecook JA, Lansingh VC, et al. Recomendaciones para el manejo de pacientes que requieren atención oftalmológica durante la pandemia de SARS-CoV-2. Rev Mex Oftalmol. 2020;94(3):103-12.
  5. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13:667-73.
  6. Shanafelt T, Ripp J, Sinai M, Trockel M. Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID- 19 Pandemic. JAMA. 2020;323(21):2133-4.
  7. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5):1729.
  8. Tsamakis K, Rizos E, Manolis A, Chaidou S, Kympouropoulos S, Spartalis E, et al. [Comment] COVID-19 pandemic and its impact on mental health of healthcare professionals. Exp Ther Med. 2020;19(6):3451-3.
  9. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. The Lancet Psychiatry. 2020;7(3):e14.
  10. Ruiz MA, Zamorano E, García-Campayo J, Pardo A, Freire O, Rejas J. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disord. 2011;128(3):277-86.
  11. Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14(1):61-8.
  12. Rajkumar R. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020;52:102066.
  13. Pappa S, Ntella V, Giannakas T, Giannakoulis V, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain Behav Immun. 2020 May 8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.